Market Place
Sourcing Support
Pfizer Drops Another Early Cancer Candidate From Seagen
19 Mar 2026 //
FIERCE BIOTECH
Pfizer Reduces 100 Jobs at Former Seagen HQ in Digital
27 Aug 2025 //
BIOSPACE
Pfizer lays off 100 workers at former Seagen HQ
26 Aug 2025 //
FIERCE PHARMA
Pfizer tacks on $1B to 2024 revenue outlook amid cost-cutting drive
31 Jul 2024 //
PRESS RELEASE
Pfizer to press pause on large M&A deals, CEO says
11 Jun 2024 //
FIERCE PHARMA
Pfizer telegraphs another round of Seagen layoffs
09 May 2024 //
FIERCE PHARMA
Seagen patent invalidated in long-running Daiichi Sankyo spat
18 Jan 2024 //
FIERCE PHARMA
Patent Office Invalidates Seagen Patent in Dispute between Daiichi and Seagen
16 Jan 2024 //
BUSINESSWIRE
Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights
13 Dec 2023 //
REUTERS
Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth
01 Nov 2023 //
BUSINESSWIRE
Pfizer’s $43 billion purchase of Seagen gets green light from EU antitrust
20 Oct 2023 //
CNBCTV18
District Court issues final judgment in patent dispute between Daiichi & Seagen
19 Oct 2023 //
PHRAMABIZ
Seagen to Highlight Overall Survival Data for PADCEV® and TIVDAK®
16 Oct 2023 //
BUSINESSWIRE
Seagen to Report Third Quarter 2023 Financial Results on November 1, 2023
12 Oct 2023 //
BUSINESSWIRE
Nurix Announces Collaboration with Seagen Combining Leading Technologies
07 Sep 2023 //
GLOBENEWSWIRE
Genmab, Seagen say Tivdak cervical cancer trial met overall survival endpoint
05 Sep 2023 //
GLOBENEWSWIRE
Seagen Second Quarter 2023 Financial Results Demonstrate Commercial Performance
02 Aug 2023 //
BUSINESSWIRE
Pfizer shuffles R&D leadership to prepare for Seagen merger
27 Jul 2023 //
FIERCE BIOTECH
US FTC seeks additional info on Pfizer`s proposed takeover of Seagen
14 Jul 2023 //
REUTERS
FTC says it wants more information about $43B Pfizer-Seagen deal
14 Jul 2023 //
ENDPTS
Seagen to Report Second Quarter 2023 Financial Results on August 2, 2023
12 Jul 2023 //
BUSINESSWIRE
Former Seagen CEO brings company HQ to Seattle after merger
29 Jun 2023 //
BIZJOURNAL
Pfizer refiles Seagen acquisition paperwork
15 Jun 2023 //
ENDPTS
Pfizer withdraws $43B Seagen buyout notification to refile
14 Jun 2023 //
FIERCE PHARMA
Second round of inflation-related rebates hits 43 drugs from Amgen and others
09 Jun 2023 //
ENDPTS
Seagen Stockholders Approve Acquisition by Pfizer
30 May 2023 //
BIOSPACE
Pfizer to raise $31 billion for Seagen takeover in largest debt offering
17 May 2023 //
REUTERS
FTC move on Amgen-Horizon doesn`t doom Pfizer-Seagen: analysts
17 May 2023 //
FIERCE PHARMA
Pfizer, Seagen kick off FTC review of $43B merger
15 May 2023 //
FIERCE PHARMA
After Pfizer-Seagen deal, analysts expect more M&A activity
09 May 2023 //
FIERCE PHARMA
Seagen to Highlight Data From Oncology Portfolio and Pipeline at the 2023 ASCO
26 Apr 2023 //
BUSINESSWIRE
In $43B buy, Seagen courted Pfizer and played the waiting game
17 Apr 2023 //
FIERCE PHARMA
Seagen to Report First Quarter 2023 Financial Results on April 27, 2023
07 Apr 2023 //
BUSINESSWIRE
Former Seagen CEO takes new role less than a year after arrest
23 Mar 2023 //
FIERCE BIOTECH
US government to impose inflation penalties on 27 drugs
16 Mar 2023 //
REUTERS
Seagen to Present Data From Broad Portfolio of Targeted Cancer Therapeutics
14 Mar 2023 //
BUSINESSWIRE
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
14 Mar 2023 //
BIOPHARMADIVE
Pfizer CEO points to IRA as a factor that made Seagen an attractive target
13 Mar 2023 //
ENDPTS
Seagen to Present at the Cowen 43rd Annual Health Care Conference
27 Feb 2023 //
BUSINESSWIRE
Pfizer in talks to buy Seagen for likely for more than $30 bln
27 Feb 2023 //
REUTERS
Daiichi Sankyo gets US patent office to restart review of Seagen patent
18 Feb 2023 //
ENDPTS
Seagen`s revenue up 25% in 2022 as growth drivers `firing`
16 Feb 2023 //
FIERCE PHARMA
Seagen Reports Fourth Quarter and Full Year 2022 Financial Results
15 Feb 2023 //
BUSINESSWIRE
Seagen to Highlight Research in Urothelial Cancer at the 2023 Symposium
13 Feb 2023 //
BUSINESSWIRE
Seagen to Host Conference Discussion of Q4 & Full Year 2022 Financial Results
19 Jan 2023 //
BUSINESSWIRE
Seagen, Astellas and Merck Announce FDA Acceptance of sBLAs for PADCEV®
20 Dec 2022 //
BUSINESSWIRE
Seagen Eyes a Key Frontline Indication for Top-Seller Adcetris
13 Dec 2022 //
BIOSPACE
Seagen to Present at the J.P. Morgan Healthcare Conference
12 Dec 2022 //
PRESS RELEASE
Seagen to Highlight ADCETRIS Clinical Progress at the 2022 ASH
01 Dec 2022 //
BUSINESSWIRE
Seagen Caps Busy Week with FDA Nod in Pediatric Hodgkin Lymphoma
12 Nov 2022 //
BIOSPACE
Seagen Announces U.S. FDA Approval of New Indication for ADCETRIS
11 Nov 2022 //
PRESS RELEASE
Seagen picks Novartis, Flagship veteran Epstein as new CEO
11 Nov 2022 //
BIOPHARMADIVE
Seagen Names David R. Epstein as Chief Executive Officer and Director
10 Nov 2022 //
BUSINESSWIRE
Seagen Appoints Sandra M. Swain, M.D., to Board of Directors
10 Nov 2022 //
PRESS RELEASE
Seagen to Highlight New Research from its Pipeline of at (SITC)
10 Nov 2022 //
PRESS RELEASE
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
10 Nov 2022 //
PRESS RELEASE
Former Novartis exec David Epstein takes top job at Seagen
10 Nov 2022 //
FIERCEPHARMA
Here’s Why Seagen (SGEN) Shares Declined in the Third Quarter
28 Oct 2022 //
FIANANCE YAHOO
Seagen Reports Third Quarter 2022 Financial Results
27 Oct 2022 //
BUSINESSWIRE
